Author

Christina Morgenstern

Observed names: C Morgenstern, C. Morgenstern, Morgenstern Christina

Institution: Medical University of Vienna

Observed institutions: University of Graz, Cancer Research UK, Vienna General Hospital, Medical University of Vienna

ORCID: 0000-0003-2943-9634

Observed ORCID: 0000-0003-2943-9634

OpenAlex ID: A5084448574

Biomarkers of NRF2 signalling: Current status and future challenges

2024 · Christina Morgenstern, Isabel Lastres-Becker, et al. · Redox Biology · 147

Diazaborine Treatment of Yeast Cells Inhibits Maturation of the 60S Ribosomal Subunit

2004 · Brigitte Pertschy, Gertrude Zisser, et al. · Molecular and Cellular Biology · 48

Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease

2022 · Sven Schneider, Katharina Poglitsch, et al. · European Respiratory Journal · 39

PDF

Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR)

2024 · Sven F. Seys, Sven Schneider, et al. · Journal of Allergy and Clinical Immunology · 36

PDF

Differential Axial Requirements for Lunatic Fringe and Hes7 Transcription during Mouse Somitogenesis

2009 · Michael Stauber, Chetana Sachidanandan, et al. · PLoS ONE · 31

PDF

Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseases

2025 · Monika Jakubowska, Vera Marisa Costa, et al. · Redox Biology · 20

Proteomic profiling and machine learning for endotype prediction in chronic rhinosinusitis

2025 · Christina Morgenstern, Tina J. Bartosik, et al. · Journal of Allergy and Clinical Immunology · 11

NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target

2026 · Sandra Tenreiro, Ana Sofia Falcão, et al. · Redox Biology · 8

Dupilumab treatment has no effect on the nasal microbiome in patients with NSAID-exacerbated respiratory disease: a longitudinal pilot study

2025 · Tina Bartosik, Petra Pjevac, et al. · Frontiers in Immunology · 7

PDF

A second Artemisia pollen peak in autumn in Vienna: reaching the point of no return?

2024 · Katharina Bastl, Maximilian Bastl, et al. · Aerobiologia · 6

PDF

Beyond 100 years of vitamin E and related molecules – Milestones and open challenges

2026 · Maria Witt-Wallert, Jeffrey Atkinson, et al. · Molecular Aspects of Medicine · 2

Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge

2026 · N. J. Campion, S. Villazala‐Merino, et al. · Allergy · 1

The Impact of Climate Change on the Urban Tree Ailanthus altissima: Insights from More than Four Decades of Pollen Data in Vienna (Austria)

2025 · Maximilian Bastl, Katharina Bastl, et al. · Plants · 1

PDF

Dupilumab Dampens Mucosal Type 2 Response During Acetylsalicylic Acid Challenge in N‐ERD Patients

2025 · J. Eckl-Dorna, C. Morgenstern, et al. · Clinical & Experimental Allergy · 1

PDF

NF-κB-mediated temporal changes in redox biology-related biomarkers across the natural menstrual cycle of eumenorrheic women

2023 · Christina Morgenstern, Gernot Faustmann, et al. · Free Radical Biology and Medicine · 1

Effects of mixed tocopherol versus α-tocopherol on biomarkers of reactive oxygen and nitrogen-induced stress and low-grade inflammation in healthy male volunteers: Comparison between smokers and non-smokers

2022 · Christina Morgenstern, Isabella Sundl, et al. · Free Radical Biology and Medicine · 1

Associations of NFE2L2 Gene Variants with Non-communicable Diseases: A Scoping Review

2026 · Christina Morgenstern, Monika Jakubowska, et al. · Open Science Framework

Baseline EPOS 2020 eligibility and real-world outcomes of dupilumab in CRSwNP: a longitudinal cohort study.

2026 · N J Campion, D P Petsiou, et al. · PubMed

NRF2 As a Guardian of Health: From an Ancient Survival Pathway to a Modern Therapeutic Target

2026 · Sandra Tenreiro, Ana Sofia Falcão, et al. · SSRN Electronic Journal

Dupilumab dampens mucosal type 2 response during acetylsalicylic acid challenge in N-ERD patients

2024 · Sven Schneider, Julia Eckl-Dorna, et al. · Research Square

PDF

Fibroblast growth factor FGF21, a regulator of oxidative stress cell responses, in early metabolic disturbances of health-to-disease transition in non-communicable diseases (NCD)

2022 · Morgenstern Christina, Faustmann Gernot, et al. · Free Radical Biology and Medicine

Decoding the in vivo Notch targetome

2008 · Christina Morgenstern, David Ish-Horowicz · Developmental Biology

Works count: 22

Citation count: 359

H-index: 8

I10-index: 7